Kiora Pharmaceuticals Inc (KPRX) stock
KPRXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as KPHMW
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$0.82−0.11 (-11.31%)
Close on Nov 18, 2026Market cap $3.65MP/E –Yield –
Kiora Pharmaceuticals price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Kiora Pharmaceuticals's price to sales ratio was 390.1× on Jul 31, 2025, against 0.8× a year earlier. Over the last 5 years it ranged from 0.6× to 478.8×, with a median of 101.5×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2025 | Jul 31, 2025 | 390.1× | +389.5 |
| 2024 | Dec 31, 2024 | 0.6× | −7.1 |
| 2020 | Apr 30, 2020 | 7.7× | −3.3 |
| 2019 | Dec 31, 2019 | 11.1× | −167.9 |
| 2018 | Dec 31, 2018 | 178.9× | −295.4 |
| 2017 | Dec 29, 2017 | 474.4× | +25.1 |
| 2016 | Dec 30, 2016 | 449.3× | – |
See a number that looks wrong?